Literature DB >> 19817857

Multifunctional host defense peptides: antiparasitic activities.

Amram Mor1.   

Abstract

Whereas significant knowledge is accumulating on the antibacterial and antifungal properties of host defense peptides (HDPs) and their synthetic mimics, much less is known of their activities against parasites. A variety of in vitro and in vivo antiparasitic assays suggest that these notorious antimicrobial compounds could represent a powerful tool for the development of novel drugs to fight parasites in the vertebrate host or to complement current therapeutic strategies, albeit the fact that HDPs essentially act by nonspecific mechanisms casts serious doubt on their ability to exert sufficient selectivity to be considered ideal candidates for drug development. This minireview summarizes recent efforts to assess the antiparasitic properties of HDPs and their synthetic derivatives, focusing on two of the most used models - Plasmodium and Leishmania species - for antiparasitic assays against the different development stages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19817857     DOI: 10.1111/j.1742-4658.2009.07358.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  25 in total

1.  Screening of antimicrobials from Caribbean sea animals and isolation of bactericidal proteins from the littoral mollusk Cenchritis muricatus.

Authors:  Carlos López-Abarrategui; Annia Alba; Loiane A Lima; Simone Maria-Neto; Ilka M Vasconcelos; Jose T A Oliveira; Simoni C Dias; Anselmo J Otero-Gonzalez; Octavio L Franco
Journal:  Curr Microbiol       Date:  2012-02-26       Impact factor: 2.188

2.  Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl.

Authors:  Yair Goldfeder; Fadia Zaknoon; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

3.  Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-acyl-lysyl.

Authors:  Hadar Sarig; Yair Goldfeder; Shahar Rotem; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

4.  Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity.

Authors:  A K Marr; S Cen; R E W Hancock; W R McMaster
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

5.  NMR model structure of the antimicrobial peptide maximin 3.

Authors:  Silvia Benetti; Patrick Brendan Timmons; Chandralal M Hewage
Journal:  Eur Biophys J       Date:  2019-02-08       Impact factor: 1.733

6.  Antiplasmodial properties of acyl-lysyl oligomers in culture and animal models of malaria.

Authors:  Fadia Zaknoon; Sharon Wein; Miriam Krugliak; Ohad Meir; Shahar Rotem; Hagai Ginsburg; Henri Vial; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

Review 7.  Topical antimicrobials for burn wound infections.

Authors:  T Dai; Y Y Huang; S K Sharma; J T Hashmi; D B Kurup; M R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2010-06

8.  Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.

Authors:  Marie Crisel B Erfe; Consuelo V David; Cher Huang; Victoria Lu; Ana Claudia Maretti-Mira; Jacquelyn Haskell; Kevin W Bruhn; Michael R Yeaman; Noah Craft
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

9.  NMR structures and interactions of temporin-1Tl and temporin-1Tb with lipopolysaccharide micelles: mechanistic insights into outer membrane permeabilization and synergistic activity.

Authors:  Anirban Bhunia; Rathi Saravanan; Harini Mohanram; Maria L Mangoni; Surajit Bhattacharjya
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

10.  Cellular response to Trypanosoma cruzi infection induces secretion of defensin α-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection.

Authors:  Candice A Johnson; Girish Rachakonda; Yuliya Y Kleshchenko; Pius N Nde; M Nia Madison; Siddharth Pratap; Tatiana C Cardenas; Chase Taylor; Maria F Lima; Fernando Villalta
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.